医学综述
醫學綜述
의학종술
MEDICAL RECAPITULATE
2015年
8期
1506-1508
,共3页
简凤萍%陈昂%周萍%关燕鸣%梁锐根
簡鳳萍%陳昂%週萍%關燕鳴%樑銳根
간봉평%진앙%주평%관연명%량예근
青春期功能性子宫出血%戊酸雌二醇%去氧孕烯炔雌醇
青春期功能性子宮齣血%戊痠雌二醇%去氧孕烯炔雌醇
청춘기공능성자궁출혈%무산자이순%거양잉희결자순
Adolescent functional uterine bleeding%Estradiol valerate%Desogestrel ethinylestradiol
目的:比较戊酸雌二醇与去氧孕烯炔雌醇治疗青春期功能性子宫出血的疗效。方法选取中山市博爱医院2010年11月至2013年10月诊治的青春期功能性子宫出血患者136例,采用随机数字表法分为戊酸雌二醇组(68例)和去氧孕烯炔雌醇组(68例)。戊酸雌二醇组患者口服戊酸雌二醇(每次3~4 mg,每日3~4次,止血后,每次2 mg,每日3次,每隔3日减少药量1/3,降至每次1 mg,每日1次,止血20 d停药),去氧孕烯炔雌醇组患者口服去氧孕烯炔雌醇片(每次2~3片,每日2次,止血后,每次1片,每日2次,止血20 d停药),比较两组患者的止血状况、临床疗效、治疗效果、不良反应发生情况。结果去氧孕烯炔雌醇组控制出血时间、完全止血时间均显著短于戊酸雌二醇组[(17±4) h比(27±6) h、(25±4) h比(36±8) h,均P<0.05],去氧孕烯炔雌醇组总有效率显著高于戊酸雌二醇组(100.0%比91.2%),去氧孕烯炔雌醇组基础体温双相比率、超声下有排卵比率、规律月经比率均显著高于戊酸雌二醇组(76.5%比33.8%、72.1%比23.5%、97.1%比60.3%,P<0.01),去氧孕烯炔雌醇组不良反应发生率显著低于戊酸雌二醇组(4.4%比14.7%,P <0.05)。结论戊酸雌二醇与去氧孕烯炔雌醇均是治疗青春期功能性子宫出血的有效药物。去氧孕烯炔雌醇的治疗效果更佳。
目的:比較戊痠雌二醇與去氧孕烯炔雌醇治療青春期功能性子宮齣血的療效。方法選取中山市博愛醫院2010年11月至2013年10月診治的青春期功能性子宮齣血患者136例,採用隨機數字錶法分為戊痠雌二醇組(68例)和去氧孕烯炔雌醇組(68例)。戊痠雌二醇組患者口服戊痠雌二醇(每次3~4 mg,每日3~4次,止血後,每次2 mg,每日3次,每隔3日減少藥量1/3,降至每次1 mg,每日1次,止血20 d停藥),去氧孕烯炔雌醇組患者口服去氧孕烯炔雌醇片(每次2~3片,每日2次,止血後,每次1片,每日2次,止血20 d停藥),比較兩組患者的止血狀況、臨床療效、治療效果、不良反應髮生情況。結果去氧孕烯炔雌醇組控製齣血時間、完全止血時間均顯著短于戊痠雌二醇組[(17±4) h比(27±6) h、(25±4) h比(36±8) h,均P<0.05],去氧孕烯炔雌醇組總有效率顯著高于戊痠雌二醇組(100.0%比91.2%),去氧孕烯炔雌醇組基礎體溫雙相比率、超聲下有排卵比率、規律月經比率均顯著高于戊痠雌二醇組(76.5%比33.8%、72.1%比23.5%、97.1%比60.3%,P<0.01),去氧孕烯炔雌醇組不良反應髮生率顯著低于戊痠雌二醇組(4.4%比14.7%,P <0.05)。結論戊痠雌二醇與去氧孕烯炔雌醇均是治療青春期功能性子宮齣血的有效藥物。去氧孕烯炔雌醇的治療效果更佳。
목적:비교무산자이순여거양잉희결자순치료청춘기공능성자궁출혈적료효。방법선취중산시박애의원2010년11월지2013년10월진치적청춘기공능성자궁출혈환자136례,채용수궤수자표법분위무산자이순조(68례)화거양잉희결자순조(68례)。무산자이순조환자구복무산자이순(매차3~4 mg,매일3~4차,지혈후,매차2 mg,매일3차,매격3일감소약량1/3,강지매차1 mg,매일1차,지혈20 d정약),거양잉희결자순조환자구복거양잉희결자순편(매차2~3편,매일2차,지혈후,매차1편,매일2차,지혈20 d정약),비교량조환자적지혈상황、림상료효、치료효과、불량반응발생정황。결과거양잉희결자순조공제출혈시간、완전지혈시간균현저단우무산자이순조[(17±4) h비(27±6) h、(25±4) h비(36±8) h,균P<0.05],거양잉희결자순조총유효솔현저고우무산자이순조(100.0%비91.2%),거양잉희결자순조기출체온쌍상비솔、초성하유배란비솔、규률월경비솔균현저고우무산자이순조(76.5%비33.8%、72.1%비23.5%、97.1%비60.3%,P<0.01),거양잉희결자순조불량반응발생솔현저저우무산자이순조(4.4%비14.7%,P <0.05)。결론무산자이순여거양잉희결자순균시치료청춘기공능성자궁출혈적유효약물。거양잉희결자순적치료효과경가。
Objective To compare the effects of estradiol valerate and desogestrel ethinylestradiol in treating adolescent functional uterine bleeding.Methods A total of 136 patients with adolescent functional uterine bleeding admitted in Zhongshan Pok Oi Hospital from Oct .2011 to Oct.2013 were selected and ran-domly divided into estradiol valerate group and desogestrel ethinylestradiol group , with 68 cases in each group.Patients in estradiol valerate group orally took estradiol valerate ( 3-4 mg/time, 3-4 times/d, after hemostasis,2 mg/time,3 times/d,every 3 day reduced dose of 1/3,until 1 mg/time,1 times/d, withdrew after 20 d of hemostasis) .Patients in desogestrel ethinylestradiol group orally took desogestrel ethinylestradiol (2-3 tablet/time,2 times /d,after hemostasis,1 tablet/time,2 times /d,withdrew after 20 d of hemostasis) . Hemostatic status, clinical efficacy, therapeutic effect, adverse reactions were compared between the two groups.Results Time of bleeding control,complete hemostasis time in desogestrel ethinylestradiol group were significantly lower than estradiol valerate group[(17 ±4) h vs(27 ±6) h,(25 ±4) h vs(36 ±8) h, P<0.05].Total effective rate of desogestrel ethinylestradiol group was significantly higher than estradiol valerate group(100.0% vs 91.2%).Dual phase ratio of basic temperature,ovulation rate under ultrasound, and ratio of regular menstruation in desogestrel ethinylestradiol group were significantly higher than those in estradiol valerate group(76.5% vs 33.8%,72.1% vs 23.5%,97.1% vs 60.3%,P<0.01).Incidence of adverse reactions in desogestrel ethinylestradiol group was significantly lower than that in estradiol valerate group(4.4% vs 14.7%,P <0.05).Conclusion Estradiol valerate and desogestrel ethinylestradiol are both effective drugs in the treatment for adolescent functional uterine bleeding ,while the therapeutic effect of desogestrel ethinylestradiol is better.